PHARM.ASPHARM.ASAMS
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank64
Year-over-Year Change
Year-over-year operating income growth rate
Latest
45.85%
↑ 807% vs avg
Percentile
P64
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
-6.48%
Historical baseline
| Period | Value |
|---|---|
| Q3 2025 | 45.85% |
| Q2 2025 | 254.02% |
| Q1 2025 | -205.07% |
| Q4 2024 | 63.19% |
| Q3 2024 | 202.80% |
| Q2 2024 | 75.50% |
| Q1 2024 | -2796.51% |
| Q4 2023 | -68.30% |
| Q3 2023 | -63.99% |
| Q2 2023 | 138.78% |
| Q1 2023 | -34.25% |
| Q4 2022 | -196.67% |
| Q3 2022 | -40.92% |
| Q2 2022 | 217.55% |
| Q1 2022 | 511.44% |
| Q4 2021 | 0.00% |
| Q2 2021 | 77.72% |
| Q1 2021 | -72.35% |
| Q4 2020 | -7.04% |
| Q3 2020 | 59.20% |
| Q2 2020 | -30.57% |
| Q1 2020 | -0.36% |
| Q4 2019 | 15.15% |
| Q3 2019 | 31.13% |
| Q2 2019 | 3.68% |
| Q1 2019 | 85.31% |
| Q4 2018 | -56.87% |
| Q3 2018 | 97.33% |
| Q2 2018 | -13.81% |
| Q1 2018 | 10.11% |
| Q4 2017 | 8.18% |
| Q3 2017 | 1105.18% |
| Q2 2017 | -82.97% |
| Q1 2017 | 357.71% |
| Q4 2016 | 55.68% |
| Q3 2016 | -9.24% |
| Q2 2016 | 7.70% |
| Q1 2016 | 6.10% |
| Q4 2015 | -12.31% |
| Q3 2015 | 2.69% |